Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Cost-Effective Mental Health: Is AI the Answer to the Therapy Affordability Crisis?
The United States faces a mental‑health affordability crisis, with typical therapy sessions costing $100‑$200 and annual expenses often exceeding 10% of a median household’s income. Patients encounter long waitlists, insurance hurdles, and time constraints that limit access to care. AI‑driven mental‑health platforms now offer 24/7, evidence‑based CBT tools at a fraction of traditional costs, positioning themselves as a bridge rather than a replacement for human therapists. A hybrid model that combines AI check‑ins with periodic human sessions could slash yearly expenses from roughly $7,800 to about $2,400 while maintaining therapeutic continuity.
Pelvic Floor PT Boosts Quality of Life, Not Just Leaks
Props to my nurse in the hospital for educating me about the importance of seeing a pelvic floor PT- not because I’m leaking but to improve quality of life👏
FDA Drug Official Moves To Hire A Friend Who Touts Unproven Claims About Antidepressants
The FDA’s acting CDER director, Dr. Tracy Beth Hoeg, is reportedly moving to hire Dr. Adam Urato, a maternal‑fetal specialist who is petitioning the agency to add boxed warnings about alleged pregnancy risks of antidepressants. Urato’s claims rely on limited...
Regular Sauna Use Lowers Cardiovascular Mortality Risk
Heat exposure through sauna bathing is associated with reduced cardiovascular mortality. JAMA Internal Medicine, 2015. Laukkanen et al. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2130724
If We Fund War, We Can Fund Healthcare
If we can afford 1 Billion dollars per day to bomb another country, we can afford healthcare for all. Prove me wrong.
Endometriosis Study Aims for Safer Diagnosis
A Worcestershire Acute NHS Trust‑led clinical trial is testing a non‑invasive electrode‑based method to diagnose endometriosis, marking the first such study within the NHS. The technique records small‑intestine muscle activity, which researchers claim shows a pattern unique to patients with...
From Questions to Institutionalisation – How to Embed Women’s Health Priorities in EU Research and Policy
The Governance Lab and CEPS used the 100 Questions Initiative to move EU women’s‑health research from priority‑setting to implementation. They propose institutionalising question‑driven research, creating a public catalogue of women’s‑health questions, and framing the field as a competitiveness priority. Embedding...
A ‘Disquieting Plateau’: Healthcare Costs Are up, but Survival Among Heart Patients Stays the Same
A new JACC analysis shows that U.S. cardiovascular mortality, which fell sharply from 2000 to 2011, has essentially stalled since 2011, hovering around 224 deaths per 100,000. During the same period, spending on cardiovascular care more than tripled, rising from...
Healthcare Organizations Are Using AI to Solve Real Problems
Dr. Ryan Ries outlines several AI deployments that are delivering tangible results in healthcare. At BreakAway Games, an Amazon Bedrock‑based virtual patient platform mimics real‑world patient variability, providing 24/7 training for nursing students and reducing reliance on standardized actors. Paynela’s...
Translucent Secures $27M for Healthcare Finance AI Platform
Translucent, an AI-native healthcare finance startup, closed a $27 million Series A round led by GV with participation from NEA, Virtue and FPV Ventures. The funding follows a $7 million seed round and will accelerate its agentic AI platform that unifies clinical, operational...
Arkansas Hospital Taps Chief Nurse
Heather Hornbuckle, RN, has been appointed chief nursing officer of Southwest Arkansas Regional Medical Center, a 25‑bed critical access hospital in Hope, Arkansas. Hornbuckle brings more than two decades of nursing leadership and bedside experience to the role. She will...
From Insights to Impact: Rare Disease Therapies with UCB’s Dr. Kim Moran — Episode 246
UCB’s Senior Vice President Dr. Kim Moran discusses the company’s rare disease pipeline, including therapies for mitochondrial TK2 deficiency, on Xtalks Life Science Podcast episode 246. Moran, who pioneered UCB’s Insights‑to‑Impact function, explains how patient‑derived data informs strategy, digital transformation,...
Maven Clinic Launches Direct-to-Consumer Platform Nationwide Featuring GLP-1 and Hormone Care
Maven Clinic, known for its B2B telehealth services covering 28 million lives, has opened a beta waitlist for a new direct‑to‑consumer platform that will be available to women across the United States. The DTC offering bundles virtual access to more...
Refurbished Hospital Shows Humanity-Driven Leadership in Zimbabwe
They refurbished the hospital… equipped it… and staffed it… and opened its doors to Zimbabweans from ALL WALKS OF life… Many have a testimony of their experience at Dr Tagwirei’s Arundel Hospital…. NOTHING says “LOVE FOR HUMANITY” better than that…...
Digital Health's New Challenge: Empowering Users without Adding Complexity
At the 2026 HIMSS Global Health Conference, leaders highlighted a growing tension in digital health: rapid innovation can add complexity for clinicians and patients. They showcased Mass General Brigham’s AI‑powered ambient documentation, which after a pilot with 800 clinicians showed...
Lonza Expands Agreement to Manufacture Gene Therapy for Transfusion-Dependent Beta-Thalassemia
Lonza has broadened its agreement with Genetix Biotherapeutics to increase manufacturing capacity for ZYNTEGLO, the sole FDA‑approved gene therapy for transfusion‑dependent beta‑thalassemia. Production will continue at Lonza’s Houston, Texas, dedicated cell‑and‑gene therapy site, with provisions to scale up for future...
Seven Ways to Skin KRAS: Emerging Approaches to Watch Out For
The article surveys seven early‑stage programmes tackling KRAS, each proposing a distinct therapeutic angle. While many firms still chase the classic model of deeper, longer, or more selective pathway blockade, these initiatives span elegant biochemical tricks to counterintuitive concepts that...
UF Health CNO: Why a 7-Day Hiring Cycle Is Crucial
UF Health appointed Janice Walker as its inaugural chief nursing officer and introduced a seven‑day recruitment cycle to prevent losing qualified nurses. Walker frames slow hiring as a "never event," shifting the process from employer‑centric to candidate‑centric. The model relies...
HIMSS Survey: 60% of Health Systems Can’t Protect Unmanaged Medical Devices
A new HIMSS‑Elisity survey reveals that 62% of health systems cannot secure unpatchable or agentless IoMT devices, while 56% struggle with basic inventory visibility. The same respondents cite microsegmentation as the preferred defense, yet 40% fear it will disrupt clinical...
The FDA Approves Leucovorin for Rare Genetic Condition and Not for Autism
The U.S. Food and Drug Administration approved leucovorin, a synthetic vitamin B9, solely for cerebral folate deficiency, a rare genetic disorder. Earlier this year, President Trump and HHS Secretary Robert Kennedy Jr. promoted the drug as an autism cure, prompting a surge in...
Supporting Multilingual Communication in NHS Healthcare Settings
The NHS serves an increasingly multilingual patient base, creating communication challenges that can jeopardise safety and equity. Professional medical translation services, such as Protranslate, offer secure, online workflows that deliver accurate documents in over 100 languages. These platforms employ subject‑matter...
Health IT Leaders Must Stay on Top of AI that Delves Into Clinical Workflows
At HIMSS 2026, Medicomp Systems CEO David Lareau warned that health systems are rapidly embedding generative AI into clinical documentation, coding and decision‑support workflows. While large language models promise efficiency, their probabilistic nature can introduce inaccuracies into patient records, jeopardizing...
Georgia System to Add 100 Residency Positions
St. Joseph’s/Candler health system in Savannah will launch a new residency program offering 103 positions across internal medicine, family medicine, cardiovascular disease fellowship, and general surgery. The initiative is backed by nearly $17 million in state funding approved in the 2026...
Brainomix Deploys AI Imaging Platform Across West Virginia University Health System Network
Brainomix has rolled out its AI imaging platform, Brainomix 360 Stroke, to all 25 sites in the West Virginia University Health System. The tool provides real‑time, automated analysis of stroke scans, helping clinicians decide on treatment and transfer. The deployment aims to...
Providence CFO to Step Down
Providence CFO Greg Hoffman will retire in June after nearly a decade with the nonprofit Catholic health system. He joined Providence in 2016, became chief transformation officer in 2019, and was appointed executive vice president and CFO in 2021. His...
Hospital Expenses Grew Twice as Fast as Prices in 2025: 4 AHA Findings
American hospitals' operating expenses surged 7.5% in 2025, more than double the growth rate of hospital prices. The AHA report highlights sharp increases in drug costs (13.6%), medical supplies (9.9%), and workforce compensation, which now accounts for roughly 60% of...
Consultation on CE-Marked Medical Devices ‘Could Mark Major Boost to Both Patients and MedTech Growth Aims’
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on granting indefinite recognition to CE‑marked medical devices in Great Britain. Around 90% of devices used in the UK already carry CE marks, and the proposals aim...
Eli Lilly CEO David Ricks Seeks 'Exit Velocity' For Pharma's Future
Eli Lilly’s chief executive David Ricks announced a strategic push to sustain the company’s recent $1 trillion revenue milestone by accelerating AI‑driven drug discovery and manufacturing. He highlighted a new partnership with Nvidia to embed generative‑AI models across the R&D pipeline, aiming...
The Circuitous Route of Prescriptions Requires Special Attention
At HIMSS 2026, Buzz Health president Joseph Kleiman highlighted a fundamental shift in the prescription journey, moving from a linear claim flow to a complex, real‑time routing model that incorporates multiple pricing checks and benefit options. Advances in API‑based integrations...
Medtronic Elevates Sean Haag to President of ENT
Medtronic has promoted Sean Haag from interim to permanent president of its ear, nose and throat (ENT) business. Haag, who joined Medtronic twenty years ago and most recently oversaw marketing and clinical for the AiBLE system, has been credited with...
MiniMed Expands Sensor Portfolio in Europe with CE Mark for MiniMed 780G
MiniMed Group, Inc. received CE Mark approval for its MiniMed 780G automated insulin delivery system to be used with Abbott's Instinct continuous glucose monitor, adding a 15‑day wear sensor to the existing 7‑day options (Guardian 4 and Simplera Sync). The Instinct sensor is...
Microsoft: AI Tools Now Handle 50M Health Questions Daily
Microsoft reported that its consumer AI tools, including Bing and Copilot, now field more than 50 million health‑related questions each day. An analysis of over 500,000 anonymized health conversations in January 2026 showed health is the top topic on mobile devices,...
Ascension Hospital in Kansas Taps New President
Patrick Avila has been named president of Ascension Via Christi Hospital in Manhattan, Kansas, effective April 20, succeeding interim leader Drew Talbott. Avila arrives with more than 25 years of healthcare leadership, most recently as CEO of Northeast Regional Medical...
A New Antibody Approach To Preventive Treatment For HIV
Researchers have engineered an antibody‑drug conjugate that simultaneously triggers HIV’s entry‑facilitating conformational shift and binds the newly exposed epitopes. In vitro tests showed the dual‑action molecule achieved seven‑ to ten‑fold greater neutralization than the antibody alone and outperformed separate mixtures...
Mankind Pharma Highlights Rising Kidney Disease Risk on World Kidney Day
Mankind Pharma used World Kidney Day to spotlight the escalating burden of chronic kidney disease (CKD) in India, where an estimated 138 million people are affected—far above the global average of 10 percent. The campaign highlighted the disease’s silent progression, noting that...
Digital Health Device Evolution: Past Decade, Next Ten Years
A 25-page executive overview of how six major categories of digital health devices evolved, and what their trajectories tell us about the future. If you want to understand the past decade of wearable evolution and the next decade of healthcare innovation,...
Emerging KRAS Combo Therapies Show Promising Progress
The KRAS niche has been a deluge of new selective and pan/multi inhibitors. Now there are combos to watch out for – we may be making progress. Here are insights on 7 of them: https://t.co/F9HmM8A4ud https://t.co/IqWw6n2m3k
STAT+: FDA Approves Leucovorin for Rare Disorder without Trial Data
The FDA has granted approval for leucovorin, a folinic‑acid formulation, to treat a rare metabolic disorder despite the absence of new clinical trial data. The decision leans on decades of off‑label use and historical safety records rather than prospective studies....
GLP‑1 Drug Linked to Longer Survival in Brain Metastases
Another potential GLP-1 drug benefit seen in people with diabetes and brain metastases for improved survival; a retrospective study that needs further assessment but intriguing https://t.co/nZm3xEYQMH https://t.co/V76S7o1MJb
Lilly's Market Cap per Employee Rivals Tech Giants
One fun takeaway from my Lilly story: looking at $LLY from a market cap/employee ratio. Far more in line with tech giants like $META $GOOG $MSFT than pharma peers like $MRK $AZN $PFE: https://t.co/pVIADCH8AU https://t.co/FJE8JLIrmO
HIMSS26: WVU Medicine Expands Abridge Ambient AI Platform Across 25 Hospitals
WVU Medicine announced expansion of Abridge’s ambient AI platform to over 2,800 clinicians across its 25‑hospital network. The rollout, driven by clinician advocacy, aims to alleviate physician burnout in rural West Virginia. Post‑implementation surveys of more than 200 providers reported...
Alzheimer’s Blood Markers Also Flag Certain Amyloidosis Types
The blood neuromarkers p-tau181 and p-tau217 that can predict and diagnose Alzheimer's disease are also abnormal in certain types of amyloidosis, indicating both some non-specificity and potential help in diagnosis of these conditions https://t.co/jodvMY6TNK
Severe COVID/Flu May Boost Lung Cancer Risk
A causal link between severe Covid or flu and lung cancer risk by impairing immunity and promoting inflammation, as shown in multiple murine models https://t.co/NvE6uIYFZh
“If We Fix Referrals, We Fix Flow, and Flow Is the Foundation of Sustainable NHS Dentistry.”
The NHS Confederation’s report highlights that fragmented dental referrals are a core barrier to sustainable NHS dentistry. Digital referral optimisation, as demonstrated by NEC Rego, standardises forms, embeds clinical guidance and delivers real‑time data to Integrated Care Systems. Early pilots in...
Lilly's CEO Pursues Sustainable ‘Exit Velocity’ to Reach Trillion‑Dollar Milestone
NEW: I took a step back in looking at Lilly's ascent to the trillion-dollar club, and CEO David Ricks' actions in attempting to find "exit velocity" in the pharma industry + stay there: https://t.co/pVIADCH8AU
I Underwent “Conversion Therapy” As a Kid. As a Psychiatrist, I Can’t Believe the Supreme Court Might Approve This.
The Supreme Court is set to decide Chiles v. Salazar, a case challenging Colorado's ban on conversion therapy for minors. The dispute centers on whether talk‑based treatments aimed at changing sexual orientation or gender identity constitute protected speech or regulated...
Cell Rejuvenation Therapy to Hit Clinic
Life Biosciences has secured FDA IND approval for ER-100, the first partial epigenetic reprogramming therapy to enter human trials. The gene‑therapy delivers OCT‑4, SOX‑2 and KLF‑4 to retinal ganglion cells via a single intravitreal injection, aiming to reset age‑related epigenetic...
The Shifting Landscape of Workers’ Compensation Pain Management
The National Council on Compensation Insurance reports that opioid costs in workers’ compensation fell an average 2.8% annually from 2012 to 2023, dropping median claim expenses from $188 to $105. Meanwhile, topical medication spend rose from $38 to $62 per...
What Is a Burr Hole Drill and How Is It Used in Brain Surgery?
A burr hole drill is a specialized neurosurgical instrument that creates a small, precise opening in the skull to grant controlled access for a range of procedures. Modern designs feature high torque and automatic disengagement once the bone is penetrated,...
STAT+: Pharmalittle: We’re Reading About the FDA Warning Novo Nordisk, Lilly Investing in China, and More
Astellas Pharma leveraged the Trump administration’s push for lower U.S. drug prices to argue for higher reimbursement for its eye drug Izervay in Japan, winning a more generous price level. Meanwhile, a review of FDA adverse event reports found that...